Decision Resources, Inc., one of the world's leading research and advisory firms focusing on pharmaceutical and health care issues, finds that pressure from expert panels, payers, and public health officials to reduce antibiotic overprescribing will limit growth of the acute exacerbations of chronic bronchitis (AECB) drug market over the next decade.

"AECB is currently overtreated with antibiotics, and experts suggest that a subset of patients with minor symptoms probably do not require antibiotic therapy," said Aarti Raja, Ph.D., analyst at Decision Resources. "However, because AECB patients often have multiple other medical problems, primary care physicians tend to err on the side of caution and prescribe antibiotics-often the 'latest and greatest'."

The new Pharmacor study entitled Acute Exacerbations of Chronic Bronchitis also finds that physicians are caught between a need to limit overprescribing and a need to deal with increasing antibiotic resistance among respiratory pathogens in the major pharmaceutical markets (United States, Germany, France, Italy, Spain, Japan, and the United Kingdom). So far, attempts by managed care organizations, insurers, and national health systems to contain the cost of treating AECB have been thwarted in part by these new generations of resistant bacteria.

About Acute Exacerbations of Chronic Bronchitis

During an acute exacerbation, breathing becomes much more difficult because of further narrowing of the airways and secretion of large amounts of mucus that is often thicker than usual. An acute exacerbation of chronic bronchitis is associated with increased frequency and severity of coughing, and is often accompanied by worsened chest congestion and discomfort.

About Pharmacor from Decision Resources

Pharmacor is a unique family of studies that assesses a host of market- impacting factors and analyzes the commercial outlook for drugs in research and development.

About Decision Resources

Decision Resources, Inc., ( is a world leader in market research publications, advisory services, and consulting designed to help clients shape strategy, allocate resources, and master their chosen markets.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

  For more information, contact:    Elizabeth Marshall    Decision Resources, Inc.    781-296-2563 

SOURCE: Decision Resources, Inc.

CONTACT: Elizabeth Marshall of Decision Resources, Inc., +1-781-296-2563,

Six Largest States Saw a 16% Increase in HMO Medicare Enrollment Between 2003 and 2004, According to New Research from InterStudy

View Now